YASUHARA CHEMICAL (4957) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Cumulative results for Q3 reflect higher revenue but lower profit, with the key characteristic being that revenue growth has not translated into Operating Income growth. Revenue was ¥113.6B (up +4.1% YoY), while Operating Income was ¥13.4B (down △3.1% YoY). Ordinary Income increased to ¥16.3B (up +3.3% YoY), and Net Income increased to ¥11.5B (up +4.2% YoY); however, this increase was primarily attributable to a ¥2.5B foreign exchange gain included in non-operating income, which should be distinguished from profit growth in the core business.

Factors Affecting Performance

【Revenue】Revenue increased 4.1% YoY to ¥113.6B. By segment, TerpeneChemicalProducts generated ¥88.5B (77.9% composition ratio) and an Operating Income margin of 22.6%, serving as the earnings pillar, while FunctionalCompounds generated ¥26.6B (23.4% composition ratio) with a margin of only 4.9%. The difference in margins between the two segments is significant, and the earnings structure is highly dependent on TerpeneChemicalProducts.

【Profit and Loss】Gross profit was ¥31.8B, representing a gross margin of 28.0%. SG&A expenses were ¥18.4B (16.2% of revenue), up from 13.6% in the previous year, while Operating Income was ¥13.4B (down △3.1% YoY) and the Operating Income margin narrowed to 11.8%. Meanwhile, Ordinary Income increased to ¥16.3B (up +3.3% YoY), supported by ¥3.6B in non-operating income (including a ¥2.5B foreign exchange gain), and Net Income was ¥11.5B (up +4.2% YoY) as extraordinary gains and losses were virtually zero. The company recorded lower profit at the operating level but higher Ordinary Income and Net Income; overall, the results are assessed as higher revenue but lower profit.

Segment Analysis

TerpeneChemicalProducts generated Revenue of ¥88.5B, Operating Income of ¥20.0B, and a margin of 22.6%, accounting for the majority of company-wide profit. FunctionalCompounds generated Revenue of ¥26.6B, Operating Income of ¥1.3B, and a margin of 4.9%, remaining low-profit and weighing on the company-wide Operating Income margin of 11.8%. The margin difference between the two segments is approximately 17.7pt, and this uneven profitability is considered one factor contributing to the contraction in the company-wide Operating Income margin.

Key Financial Indicators

【Profitability】The Operating Income margin was 11.8% and the Net Income margin was 10.1%. While the Net Income margin improved from the previous year, the Operating Income margin contracted. The Ordinary Income margin was 14.3%, exceeding the Operating Income margin, with the difference primarily attributable to the foreign exchange gain.【Cash Flow Quality】DSO was approximately 65 days, DIO was approximately 372 days, and CCC was approximately 416 days, all indicating extended periods. Inventory of ¥111.3B accounted for 62.4% of current assets, and there has been no progress in reducing inventory and accounts receivable relative to revenue growth.【Investment Efficiency】ROE was 5.2%, decomposed into a Net Income margin of 10.1%, total asset turnover of 0.44x, and financial leverage of 1.16x. The low asset turnover is constraining ROE.【Financial Soundness】The Equity Ratio was 86.4%. Against interest-bearing debt of ¥10.0B, cash and deposits were ¥32.2B, indicating a net cash position, while the current ratio was extremely high at 1,286.8%.

Cash Flow Analysis

As disclosed figures for Operating Cash Flow are unavailable, cash trends are analyzed based on changes in the balance sheet. Cash and deposits declined from ¥60.2B in the previous year to ¥32.2B, while interest-bearing debt was substantially reduced from a combined ¥36.5B to ¥10.0B on a short- and long-term basis. Inventory totaled ¥111.3B, comprising raw materials of ¥57.1B, work in process of ¥25.7B, and finished goods of ¥28.4B, representing a modest increase from ¥110.0B in the previous year; inventory levels therefore remain elevated even amid revenue growth. Net assets increased from ¥210.7B to ¥222.9B, indicating continued accumulation of profits. At the same time, the simultaneous decline in cash and reduction in debt suggest the possibility that funds on hand were allocated to debt repayment during the period.

Earnings Quality

The increase in Net Income was supported in part by non-operating factors rather than recurring business activities. Ordinary Income totaled ¥16.3B, comprising Operating Income of ¥13.4B plus a net non-operating income contribution of ¥2.9B (non-operating income of ¥3.6B - non-operating expenses of ¥0.7B), of which the ¥2.5B foreign exchange gain was the primary contributor. Extraordinary gains and losses had virtually no impact, consisting solely of an extraordinary gain of ¥0.01B, and the majority of Net Income of ¥11.5B was derived from profit at the Ordinary Income level. However, foreign exchange gains can reverse depending on market conditions. Given that Operating Income declined YoY, the quality of profit growth should be assessed as dependent more on non-operating factors than on core business factors.

Earnings Forecast and Guidance

Progress rates against the full-year forecast were 73.7% for Revenue, 94.3% for Operating Income, 109.6% for Ordinary Income, and 112.6% for Net Income. Compared with a standard Q3 progress rate of 75%, the profit items are substantially ahead of schedule. The full-year forecast itself assumes Revenue growth of +5.1%, against declines of △22.1% in Operating Income, △21.1% in Ordinary Income, and △25.8% in Net Income, representing a plan that anticipates a significant deterioration in profit margins in Q4. The high cumulative profit progress relative to the forecast suggests that the full-year forecast may have been set conservatively; however, it should be noted that the foreign exchange gain contributed to the acceleration in progress.

Shareholder Returns

The full-year dividend forecast is ¥6.00 per share, unchanged from the previous year's full-year dividend. Based on current-period Net Income of ¥11.5B, the Payout Ratio is approximately 5.7%, which is low, indicating a light dividend burden relative to earnings. Given the financial foundation of cash and deposits of ¥32.2B, interest-bearing debt of ¥10.0B, and an Equity Ratio of 86.4%, dividend sustainability is considered high.

Risk Factors

1. Inventory accumulation risk: Total inventory was ¥111.3B, and annualized DIO reached approximately 372 days, creating the possibility of valuation losses or production adjustments when demand fluctuates.

2. Accounts receivable collection risk: Annualized DSO was approximately 65 days, while CCC extended to approximately 416 days. Prolonged collection periods are tying up working capital.

3. Foreign exchange fluctuation risk: The ¥2.5B foreign exchange gain that boosted Ordinary Income may reverse depending on market conditions. As Operating Income declined YoY, the dependence of increases in Ordinary Income and Net Income on foreign exchange factors requires monitoring.

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (manufacturing)

Profitability and Returns

The Company's Operating Income margin and Net Income margin both exceed the industry median, placing the Company in the upper tier of the industry.

Growth and Capital Efficiency

The Revenue growth rate is slightly above the industry median but has not reached the upper bound of the IQR, remaining in the mid-to-upper range.

※Source: Compiled by the Company

Key Points from the Financial Results

1. Despite higher revenue, Operating Income declined △3.1% YoY, while increases in Ordinary Income and Net Income were supported by the ¥2.5B foreign exchange gain. It is necessary to distinguish core business profit momentum from the boost provided by non-operating factors.

2. Due to inventory of ¥111.3B (annualized DIO of approximately 372 days) and the extended collection period for accounts receivable (DSO of approximately 65 days), CCC reached approximately 416 days. Working capital has not been reduced even amid revenue growth, leaving room to improve asset efficiency.

3. Progress rates for profit against the full-year forecast were high, at 109.6% for Ordinary Income and 112.6% for Net Income. While this suggests potential upside relative to the full-year forecast for lower profit (Operating Income △22.1%), the breakdown of progress includes the contribution from foreign exchange gains.

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. Industry benchmarks are reference information compiled by the Company based on publicly available earnings data. Investment decisions should be made at your own responsibility, and you should consult a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 performance was resilient at the net-income level, but operating profitability softened despite modest sales growth. Revenue rose 4.1% YoY to ¥11.36bn on a cumulative nine-month basis. Gross profit increased 11.0% YoY to ¥3.18bn, materially outpacing revenue growth. The gross margin expanded by approximately 173bp YoY to 28.0%, indicating improved gross-level pricing, product mix, or manufacturing cost absorption. However, SG&A expense increased 24.1% YoY to ¥1.84bn, substantially faster than both revenue and gross profit. Consequently, operating income declined 3.1% YoY to ¥1.34bn. The operating margin contracted by approximately 87bp YoY to 11.8%, though it remains within the good 8–15% profitability range. Ordinary income nevertheless grew 3.3% YoY to ¥1.63bn because non-operating income rose to ¥359m from ¥213m. Foreign-exchange gains of ¥248m were the principal contributor to the non-operating improvement and equaled 18.5% of operating income. Net income increased 4.2% YoY to ¥1.15bn, with the net margin effectively stable at 10.1%. The effective tax rate was 29.3%, consistent with the 0.707 tax-burden factor and not indicative of an unusual tax benefit. The reported annualized ROE was 6.9%, below the 8% threshold generally associated with an adequate equity return. The balance sheet is exceptionally liquid, with a 12.87x current ratio, 86.4% equity ratio, and only ¥1.00bn of interest-bearing debt. Balance-sheet deleveraging was substantial, as long-term loans declined ¥849m YoY while cash and deposits fell ¥2.80bn. The principal operating concern is working-capital intensity: annualized DSO was 65 days, DIO was 372 days, and the annualized cash conversion cycle was 416 days. Full-year guidance is conservative relative to nine-month actual results, as cumulative ordinary income and net income already exceed the full-year forecasts. The implied Q4 outcome under unchanged guidance would be a loss at the operating, ordinary, and net-income levels, making the treatment of the forecast and inventory monetization key issues for the remainder of FY2026.

Profitability Analysis

The reported annualized ROE of 6.9% decomposes into a 10.1% net profit margin, 0.587x asset turnover, and 1.16x financial leverage. The low financial leverage reflects the company's predominantly equity-funded capital structure rather than a debt-driven return profile. Profitability is therefore primarily supported by margin rather than leverage, while asset turnover remains modest for a manufacturer with substantial inventory and fixed assets. Gross margin improved to 28.0% from approximately 26.3% in the prior-year period, an expansion of about 173bp. This was offset below gross profit by SG&A expense growth of 24.1% YoY, versus revenue growth of 4.1%, producing operating-margin compression to 11.8% from approximately 12.6%. The largest adverse operating change was therefore SG&A deleverage rather than production cost inflation. Operating income fell ¥42m YoY despite a ¥315m increase in gross profit, because the ¥357m increase in SG&A more than absorbed the gross-profit gain. Ordinary income exceeded operating income by ¥289m, principally reflecting ¥248m of FX gains, as well as ¥43m of interest income and ¥14m of dividend income, partly offset by ¥10m of interest expense. The 5-factor DuPont interest-burden factor of 1.217 is above 1.0 because non-operating income exceeded financing costs; this supports reported earnings but is less recurring than operating profit. The ¥248m FX gain represents a material 18.5% of operating income and should not be treated as a substitute for sustainable operating-margin expansion. Net margin of 10.1% is strong in absolute terms, but annualized ROE of 6.9% remains constrained by the low turnover of the asset base and limited leverage. With operating margin still above 10%, the core earnings base remains profitable, but a sustained reduction in SG&A-to-sales or improved inventory productivity would be necessary to raise returns on equity structurally.

Growth Assessment

Nine-month revenue growth of 4.1% YoY demonstrates continued top-line expansion, although the pace is moderate. Gross profit growth of 11.0% was stronger than sales growth, supporting the conclusion that gross-level profitability improved during the period. Operating profit did not convert this gross-profit improvement because SG&A increased at a much faster 24.1% rate. Net-income growth of 4.2% was supported by the increase in non-operating income, particularly FX gains, rather than by operating-income growth. The earnings profile is therefore mixed: gross-margin momentum is constructive, while operating leverage is currently negative. The full-year revenue forecast of ¥15.40bn implies a nine-month progress rate of 73.7%, slightly below the standard Q3 progress rate of 75.0% by 1.3 percentage points. By contrast, operating-income progress is 94.3%, 19.3 percentage points above the standard 75.0% Q3 level. Ordinary-income progress is 109.6% and net-income progress is 112.6%, meaning both measures have already surpassed the stated full-year forecasts. The unchanged forecast implies Q4 revenue of approximately ¥4.05bn but operating loss of approximately ¥81m, ordinary loss of approximately ¥142m, and net loss of approximately ¥129m. Such a profile may reflect expected seasonal cost, inventory valuation, pricing, or other year-end effects; however, it also creates a high bar for forecast interpretation. Inventory composition is weighted toward raw materials at 51.3% of total inventory, followed by finished goods at 25.6% and work in process at 23.1%. The high raw-material balance suggests meaningful exposure to input-cost movements and the need to convert procurement into production and sales efficiently. For a chemical manufacturer, demand conditions in downstream industrial markets, raw-material pricing, and foreign exchange can all affect the durability of recent gross-margin improvement.

Financial Health

Financial health is strong, supported by ¥22.29bn of equity against total assets of ¥25.80bn and an equity ratio of 86.4%. Total liabilities were only ¥3.52bn, equivalent to 13.6% of total assets. The current ratio and quick ratio were both 12.87x, far above the 1.0x warning threshold and indicating ample near-term liquidity. Working capital was ¥16.46bn, providing a substantial liquidity cushion. Interest-bearing debt was limited to ¥1.00bn of long-term loans, producing a conservative debt-to-equity ratio of 0.16x and debt-to-capital ratio of 4.3%. There is no leverage warning, as D/E is well below the 2.0x risk threshold. Interest coverage was exceptionally strong at 133.7x, and interest expense was only ¥10m. The maturity profile is favorable because reported interest-bearing debt is long term while current assets exceed current liabilities by ¥16.46bn. Cash and deposits declined ¥2.80bn YoY to ¥3.22bn, a 46.5% reduction, while long-term loans fell ¥849m, or 45.9%. This combination indicates significant deleveraging and/or deployment of cash rather than financial stress, given the residual liquidity and low debt burden. Accounts payable increased ¥175m YoY, or 37.4%, to ¥643m, partly supporting working-capital financing but remaining small relative to inventories. Investment securities increased to ¥1.72bn from ¥1.46bn, and their 6.7% share of total assets means market-value movements can affect comprehensive equity. Directors' retirement-benefit provisions of ¥494m and retirement-benefit provisions of ¥629m are notable non-debt obligations within the liability structure, although the overall solvency buffer is substantial.

Notable B/S Changes

Cash and deposits: -¥2.80bn (-46.5%) to ¥3.22bn - cash declined materially, but concurrent deleveraging and a 12.87x current ratio indicate that liquidity remains strong. Long-term loans: -¥849m (-45.9%) to ¥1.00bn - significant debt repayment further strengthened an already conservative capital structure. Accounts payable: +¥175m (+37.4%) to ¥643m - supplier financing increased, though it remains limited relative to the ¥11.13bn inventory balance and does not offset the high cash-conversion-cycle burden. Work in process: +¥414m (+19.2%) to ¥2.57bn - rising production-stage inventory warrants monitoring alongside the 372-day annualized inventory period.

Cash Flow Quality

The balance-sheet working-capital profile is the principal available indicator of cash-conversion quality. Annualized DSO of 65 days exceeds the 60-day alert threshold, indicating slower collection than the stated manufacturing benchmark. Annualized DIO of 372 days is exceptionally high relative to the 90-day warning level and is the most significant earnings-quality and operating-efficiency concern. The annualized cash conversion cycle of 416 days also materially exceeds the 120-day warning threshold. These alerts are rooted in a very large inventory balance of ¥11.13bn, equivalent to 98.0% of nine-month revenue and 43.1% of total assets. Raw materials of ¥5.71bn represent 51.3% of inventory, work in process of ¥2.57bn represents 23.1%, and finished goods of ¥2.84bn represents 25.6%. Inventory increased modestly from ¥10.80bn in the prior-year period to ¥11.13bn, with the increase concentrated in work in process, which rose ¥414m, or 19.2%. The high DIO may be partly consistent with specialty chemical production cycles and strategic raw-material holdings, but its magnitude leaves the company exposed to demand shortfalls, price declines, obsolescence, and inventory valuation pressure. Receivables increased only ¥33m YoY to ¥2.71bn, so the elevated DSO is less a result of a sharp balance-sheet deterioration than of the relationship between receivables and sales. Accounts payable rose ¥175m YoY to ¥643m, but supplier credit is insufficient to offset the cash tied up in inventory and receivables. The quality alerts therefore have a direct investment-thesis impact: reported profit and strong liquidity need to be assessed alongside the capacity to convert inventories into cash without margin concessions. FX gains also contributed ¥248m to ordinary income, increasing the importance of distinguishing operating cash generation from accounting earnings in subsequent periods.

Dividend Sustainability

The declared Q2 dividend was ¥6.00 per share. The calculated dividend payout ratio was 5.7% of nine-month net income, indicating a very conservative distribution burden. Against the full-year EPS forecast of ¥112.59, a ¥6.00 per-share annual dividend would imply an approximately 5.3% payout ratio. Retained earnings were ¥19.41bn, far exceeding the cash requirement implied by the current dividend level. The company also has substantial liquidity, low leverage, and strong interest coverage, which support the financial capacity to maintain the stated dividend. Dividend sustainability is therefore strong on an earnings, retained-capital, and balance-sheet basis. However, the large inventory commitment and 416-day annualized cash conversion cycle mean the pace of cash release from working capital remains relevant to capital-allocation flexibility. The disclosed payout ratio relates to dividends only; no total return ratio is calculated.

Risk Assessment

Business risks include Working-capital risk is high: annualized DIO of 372 days and a 416-day annualized cash conversion cycle indicate a substantial amount of capital tied up in inventories., Chemical-manufacturing inventory risk is material because raw materials account for 51.3% of inventory; shifts in feedstock prices, downstream demand, or selling prices could require margin concessions or inventory write-downs., Operating-leverage risk increased during the period, as SG&A rose 24.1% YoY while revenue grew only 4.1%, reducing operating income by 3.1%., Foreign-exchange exposure is meaningful: FX gains of ¥248m contributed 18.5% of operating income, so a reversal in currency conditions could reduce ordinary income., Receivables collection efficiency requires monitoring, as annualized DSO of 65 days exceeds the 60-day alert threshold..

Financial risks include Liquidity and refinancing risk are low, given a 12.87x current ratio, ¥16.46bn of working capital, 0.16x D/E, and 133.7x interest coverage., Cash balances fell 46.5% YoY to ¥3.22bn; while the reduction coincided with debt repayment and does not currently threaten liquidity, further cash deployment would reduce the buffer against inventory-related cash needs., Investment securities of ¥1.72bn, or 6.7% of assets, introduce market-value sensitivity to comprehensive equity..

Key concerns include The most material issue is the combination of very high inventory days, elevated receivable days, and a 416-day cash conversion cycle., The earnings mix shifted toward non-operating FX gains while operating income declined, reducing the recurrence quality of the ordinary-income increase., Full-year guidance is inconsistent with the nine-month run rate: net income and ordinary income have already exceeded forecast, while operating income is at 94.3% of forecast., ROE of 6.9% is below the 8% benchmark despite high net margin, reflecting modest asset turnover and surplus-equity intensity..

Investment Implications

Key takeaways include Gross-margin expansion to 28.0% is a positive operating development, but it was more than offset by SG&A deleverage, leaving operating income down 3.1% YoY., Ordinary-income and net-income growth were aided by ¥248m of FX gains; core operating performance should be evaluated separately from this non-operating contribution., The company has an exceptionally strong balance sheet, with 86.4% equity ratio, 0.16x D/E, 4.3% debt-to-capital, and 133.7x interest coverage., Working-capital efficiency is the central issue, with annualized DSO of 65 days, DIO of 372 days, and CCC of 416 days., The stated full-year forecast implies a sharply weaker Q4 profit outcome, making forecast revision, year-end cost developments, and inventory trends important..

Metrics to watch include Operating margin and SG&A-to-sales ratio, Gross margin durability amid raw-material and product-price movements, Inventory balance, inventory days, and the raw-material/WIP/finished-goods mix, Receivable days and cash conversion cycle, FX gains or losses relative to operating income, Full-year forecast revision and implied Q4 profitability, Cash balance and progress of long-term debt repayment.

Regarding relative positioning, Relative to typical manufacturing solvency benchmarks, the company is conservatively capitalized and highly liquid. Relative to profitability benchmarks, its 11.8% operating margin and 10.1% net margin are sound, but its annualized 6.9% ROE is below the preferred return threshold. Relative to manufacturing working-capital benchmarks, the 372-day annualized DIO and 416-day annualized cash conversion cycle are materially weak and represent the clearest operational constraint.